Nonprescription Drugs Advisory Committee Roster
As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info
Current Number of Vacancies = 8
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Chairperson
Vacant
Designated Federal Officer
Takyiah Stevenson, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug and Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
(301) 796-9001 Fax: (301) 847-8533
Email: NDAC@fda.hhs.gov
+Helmut Albrecht, MD, MS, FFPM
Expertise: Drug Development
Term: 6/11/2024 – 10/31/2027
Chief Scientific Officer
Alitair Pharmaceuticals
55 Madison Avenue
Morristown, New Jersey 07960
Kristy Brittain, PharmD, BCPS, CDCES
Expertise: Nonprescription Therapeutics and Diabetes Care
Term: 6/1/2023 – 5/31/2027
Professor, Medical University of South Carolina College of Pharmacy
Clinical Pharmacy Specialist. MUSC Health
173 Ashley Avenue, MSC 140
Charleston, South Carolina 29425
**W. Greg Collier, PhD
Expertise: Healthcare Regulatory, Product Safety, and Research & Product Development
Term: 6/11/2024 – 10/31/2027
Regulatory Affairs Consultant
121 Brickwell Lane
Pawleys Island, South Carolina, 29585
Diane B. Ginsburg, PhD, MS, RPh, FASHP
Expertise: Biomedical Ethics and Pharmacy Law
Term: 6/1/2022 – 5/31/2026
Clinical Professor, Pharmacy Practice Division
Associate Dean for Healthcare Partnerships The University of Texas at Austin
College of Pharmacy
2409 University Avenue, STOP A1900
Austin, Texas 78712
*Consumer Representative (Vacant)
**Industry Representative (non voting)
+Alternate Industry Representative (non-voting)